IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VALSECCHI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.670
EU - Europa 1.940
AS - Asia 1.067
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
SA - Sud America 6
Totale 6.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.647
CN - Cina 612
PL - Polonia 472
UA - Ucraina 408
IT - Italia 290
DE - Germania 280
SG - Singapore 186
GB - Regno Unito 127
FI - Finlandia 122
HK - Hong Kong 96
IE - Irlanda 72
FR - Francia 64
TR - Turchia 60
IN - India 54
RU - Federazione Russa 25
BE - Belgio 22
CA - Canada 20
VN - Vietnam 20
CZ - Repubblica Ceca 19
SE - Svezia 12
ID - Indonesia 10
IR - Iran 8
AU - Australia 7
HU - Ungheria 7
NL - Olanda 7
A1 - Anonimo 5
AT - Austria 5
MA - Marocco 5
SA - Arabia Saudita 5
EU - Europa 4
PH - Filippine 4
PK - Pakistan 4
JP - Giappone 3
MU - Mauritius 3
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
HN - Honduras 2
NZ - Nuova Zelanda 2
PE - Perù 2
AR - Argentina 1
BD - Bangladesh 1
EE - Estonia 1
EG - Egitto 1
FK - Isole Falkland (Malvinas) 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MX - Messico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 6.710
Salva come PNG Salva come JPEG
Città #
Fairfield 487
Warsaw 471
Woodbridge 370
Jacksonville 314
Ashburn 294
Ann Arbor 260
Houston 235
Chandler 230
Seattle 179
Wilmington 177
Cambridge 167
Singapore 145
New York 137
Princeton 137
Nanjing 97
Hong Kong 96
Helsinki 92
Beijing 91
Dearborn 80
Dublin 72
Brescia 66
Istanbul 57
Shenyang 47
Jinan 45
Nanchang 44
Milan 42
Boardman 36
Des Moines 36
Hebei 34
Lancaster 34
Changsha 33
Tianjin 33
Munich 27
Jiaxing 23
Los Angeles 22
Shanghai 21
Dong Ket 20
Ningbo 17
San Diego 17
Zhengzhou 17
Brussels 16
Brno 15
Lanzhou 14
Haikou 13
London 12
Norwalk 12
Toronto 12
Washington 12
San Francisco 11
Taizhou 11
Rome 10
Hangzhou 9
Orange 9
Guangzhou 8
Jakarta 8
San Mateo 8
Fuzhou 7
Kunming 7
Leawood 7
Manchester 7
Taiyuan 7
Trieste 7
Gent 6
Hefei 6
Tehran 6
Mantova 5
Nürnberg 5
Tulsa 5
Vienna 5
Amsterdam 4
Bergamo 4
Olomouc 4
Ottawa 4
Pune 4
Rabat 4
Turin 4
Verona 4
Augusta 3
Bolzano 3
Changchun 3
Chengdu 3
Cologno Monzese 3
Columbia 3
Frankfurt am Main 3
Iesi 3
Jeddah 3
Kilburn 3
Manila 3
Phoenix 3
Redwood City 3
Sydney 3
Bordighera 2
Budapest 2
Castelli Calepio 2
Chicago 2
Chiswick 2
Esslingen am Neckar 2
Favara 2
Flero 2
Gravina in Puglia 2
Totale 5.154
Salva come PNG Salva come JPEG
Nome #
New Copy Number Variations in Schizophrenia 268
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 264
Farmacoterapia antipsicotica e disturbi cognitivi. 198
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 169
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. 138
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 137
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 134
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 134
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 132
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 128
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 127
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 124
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 122
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 120
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 118
The role of the cytochine network in schizophrenia: an overview. 115
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 114
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 113
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 111
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 111
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 111
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 110
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 107
Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. 107
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 106
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 104
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 104
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. 102
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia 102
Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy. 100
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review 100
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 98
A multimodal imaging study of never-medicated adults with schizophrenia 97
Analysis of Copy Number Variations in Schizophrenia Italian Patients 95
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 94
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 93
New Copy Number Variations in Schizophrenia Italian Patients 89
Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. 89
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 89
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 88
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder 88
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 88
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 88
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 86
Mitochondrial DNA haplogroups and age at onset of schizophrenia 85
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. 83
Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia. 81
Detection of high level of autozygosity in a group of Italian schizophrenia patients 80
Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia. 80
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 78
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 76
Manuale di clinica e riabilitazione psichiatrica. Dalle conoscenze teoriche alla pratica dei servizi di salute mentale. Vol. 2: Riabilitazione psichiatrica 71
Cerebrovascular accidents in elderly people treated with antipsychotic drugs. A systematic review 71
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 70
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 70
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 67
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 63
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 63
Implementing cognitive rehabilitation interventions for schizophrenia patients in mental health services: Focus on Integrated Psychological Therapy (IPT) 61
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 59
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 59
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 58
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 58
Panic disorder with and without comorbidity: data on epidemiology, course and treatment outcome. 57
Esperienze di switch a cariprazina in pazienti affetti da schizofrenia con ricorrenze 54
THE FACTOR STRUCTURE FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN PHARMACOGENETICS: 102T/C 5-HT2A POLYMORPHISM AND RESPONSE TO RISPERIDONE 52
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 49
La comorbidità per uso di sostanze nei disturbi psicotici e nella schizofrenia. 48
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 37
Paliperidone palmitate in short- and long-term treatment of schizophrenia 35
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 28
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 6
Totale 6.911
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.421 0 0 0 0 117 230 191 203 160 203 216 101
2020/20211.126 33 118 31 114 69 94 75 117 141 139 136 59
2021/2022577 45 105 15 32 7 23 27 33 28 58 56 148
2022/2023639 86 9 6 68 46 176 4 67 96 11 40 30
2023/2024777 41 14 70 82 46 196 31 21 119 29 18 110
2024/2025387 19 30 15 171 152 0 0 0 0 0 0 0
Totale 6.911